EX-10.17 4 s100412_ex10-17.htm EX-10.17 JOINT RESEARCH AND DEVELOPMENT AGREEMENT Between THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY AND SECOND SIGHT MEDICAL PRODUCTS, INC.Joint Research and Development Agreement • May 5th, 2020 • Maryland
This Joint Research and Development Agreement (“Agreement”) is made and entered into by and between The Johns Hopkins University Applied Physics Laboratory LLC (“JHU/APL”), and Second Sight Medical Products, Inc. (“Company”) hereinafter collectively referred to as the Parties.
EX-10.17 11 s100332_ex10-17.htm EX-10.17 JOINT RESEARCH AND DEVELOPMENT AGREEMENT Between THE JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY AND SECOND SIGHT MEDICAL PRODUCTS, INC.Joint Research and Development Agreement • May 5th, 2020 • Maryland
This Joint Research and Development Agreement (“Agreement”) is made and entered into by and between The Johns Hopkins University Applied Physics Laboratory LLC (“JHU/APL”), and Second Sight Medical Products, Inc. (“Company”) hereinafter collectively referred to as the Parties.
JOINT RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN UNIVERSITI SAINS MALAYSIA AND ABC SDN BHD IN RELATION TO THE DEVELOPMENT OF ……………..Joint Research and Development Agreement • September 8th, 2020
JOINT RESEARCH AND DEVELOPMENT AGREEMENT THIS JOINT RESEARCH AND DEVELOPMENT AGREEMENT is made on the ___________ day of _____________ 20 (hereinafter referred to as “Agreement”);
ContractJoint Research and Development Agreement • May 14th, 2016
[WARNING - This sample agreement is only one possible example and is for reference purposes only. It may not meet the needs of specific transactions, and no recommendation is made as to the content of any of the clauses contained herein. Please consider the content of the individual clauses contained herein by also referring to the content of the main text of the Report. You should consult a qualified attorney for your specific needs. Neither the Japan External Trade Organization (JETRO) nor the parties involved in the preparation of this sample agreement assume any responsibility or liability for any use hereof.]
Exhibit 10.17 JOINT RESEARCH AND DEVELOPMENT AGREEMENT Party A: Shandong Shengda Technology Co., Ltd Party B: Qingdao University of Science and Technology In line with the principle of reciprocity and mutual benefit and the operational mechanism of...Joint Research and Development Agreement • November 16th, 2006 • Zeolite Exploration Co • Mining & quarrying of nonmetallic minerals (no fuels)
ContractJoint Research and Development Agreement • December 11th, 2019
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (the “Agreement”) By and Between CELLSEED INC. (“CELLSEED”) And EMMAUS MEDICAL INC. (“EMMAUS”)Joint Research and Development Agreement • October 6th, 2011 • Emmaus Life Sciences, Inc. • Blank checks
NOW, THEREFORE, in consideration of the mutual promises and undertakings set forth herein, and intending to be legally bound hereby, CELLSEED and EMMAUS do hereby agree and acknowledge as follows:
ADDENDUM TO JOINT RESEARCH AND DEVELOPMENT AGREEMENT (the “Agreement”) By and Between CELLSEED INC. (“CELLSEED”) And EMMAUS MEDICAL INC. (“EMMAUS”)Joint Research and Development Agreement • May 8th, 2014 • Emmaus Life Sciences, Inc. • Blank checks
NOW, THEREFORE, in consideration of the mutual promises and undertakings set forth herein, and intending to be legally bound hereby, CELLSEED and EMMAUS do hereby agree and acknowledge as follows:
JOINT RESEARCH AND DEVELOPMENT AGREEMENTJoint Research and Development Agreement • November 14th, 2011 • Protea Biosciences Group, Inc. • Pharmaceutical preparations
LABORATOIRES MAYOLY SPINDLER SAS, a corporation created and organized under French laws, having its registered office at 6, avenue de l’Europe, 78400 Chatou, France, represented by its President, SCORPIUS SAS, a corporation created and organized under French laws, having its registered office at 55 rue Jouffroy d’Abbans, 75017 Paris, France, itself being represented by its President Mr. Jean-Nicolas VERNIN;
JOINT RESEARCH AND DEVELOPMENT AGREEMENTJoint Research and Development Agreement • September 9th, 2011 • Protea Biosciences Inc. • Blank checks
LABORATOIRES MAYOLY SPINDLER SAS, a corporation created and organized under French laws, having its registered office at 6, avenue de l’Europe, 78400 Chatou, France, represented by its President, SCORPIUS SAS, a corporation created and organized under French laws, having its registered office at 55 rue Jouffroy d’Abbans, 75017 Paris, France, itself being represented by its President Mr. Jean-Nicolas VERNIN;
